Study Summary
This trial will compare automated breast ultrasound (ABUS) to handheld ultrasound (HHUS) for screening women who have had breast reconstruction after breast cancer.
- Breast Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Up to 1 year
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Screening (automated breast ultrasound, handheld ultrasound)
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Ultrasonography · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Female Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the present enrollment number for this research project?
"Affirmative. Per information hosted on clinicaltrials.gov, this investigation is currently accepting applications from potential participants. This trial was initially published on November 18th 2022 and recently revised on the 21st of that same month. A total of 30 individuals need to be enrolled at one site for the study's completion." - Anonymous Online Contributor
Are there still open slots for participants in this clinical study?
"Indeed, clinicaltrials.gov indicates that this research is still open for participants. The trial was launched on November 18th 2022 and has seen recent activity on the 21st of the same month. 30 individuals are being sought to join this single-site study." - Anonymous Online Contributor